methamphetamine has been researched along with Agitation, Psychomotor in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, S; Kim, M; Kim, S; Kim, Y; Lee, S; Seo, M | 1 |
| Aarde, SM; Creehan, KM; Dickerson, TJ; Huang, PK; Taffe, MA | 1 |
| Hall, FS; Kitanaka, J; Kitanaka, N; Kubo, H; Nishiyama, N; Takahashi, H; Takemura, M; Tanaka, K; Uhl, GR; Watabe, K | 1 |
| Hirose, W; Inoue, M; Ishikawa, C; Kassai, M; Kato, T; Kitaichi, M; Shimizu, I; Takata, M; Yoshida, K | 1 |
| Dargan, PI; Wood, DM | 1 |
| Kim, HW; Kim, KW; Kwon, YB; Li, J | 1 |
| Auten, JD; Clark, RF; Combs, DJ; Gaspary, MJ; Matteucci, MJ | 1 |
| Hara, K; Hayashida, M; Mashiko, K; Ohno, Y; Saito, N; Uekusa, K; Waters, B | 1 |
| Brooks, DJ; Gerhard, A; Pavese, N; Piccini, P; Rimoldi, O | 1 |
| Carter, CS; Leamon, MH; Moore, CD; Natsuaki, Y; Nordahl, TE; Salo, R; Waters, C | 1 |
| Ha, RR; Jang, CG; Kim, HC; Kwon, SH; Lee, KW; Lee, SY; Tian, YH; You, IJ | 1 |
1 trial(s) available for methamphetamine and Agitation, Psychomotor
| Article | Year |
|---|---|
Cardiovascular effects of methamphetamine in Parkinson's disease patients.
Topics: Adrenergic Fibers; Analysis of Variance; Blood Pressure; Brain; Catecholamines; Dopamine Agents; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Injections, Intravenous; Levodopa; Male; Methamphetamine; Middle Aged; Myocardium; Parkinson Disease; Presynaptic Terminals; Psychomotor Agitation; Tomography, Emission-Computed | 2004 |
11 other study(ies) available for methamphetamine and Agitation, Psychomotor
| Article | Year |
|---|---|
Exercise Pills for Drug Addiction: Forced Moderate Endurance Exercise Inhibits Methamphetamine-Induced Hyperactivity through the Striatal Glutamatergic Signaling Pathway in Male Sprague Dawley Rats.
Topics: Animals; Corpus Striatum; Dopamine; Glutamic Acid; Glycogen Synthase Kinase 3 beta; Male; Methamphetamine; Physical Conditioning, Animal; Proto-Oncogene Proteins c-akt; Psychomotor Agitation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Running; Signal Transduction | 2021 |
The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.
Topics: Animals; Behavior, Animal; Benzodioxoles; Body Temperature Regulation; Designer Drugs; Dose-Response Relationship, Drug; Hyperkinesis; Infusions, Intravenous; Injections, Subcutaneous; Male; Methamphetamine; Motor Activity; Psychomotor Agitation; Psychotropic Drugs; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; Self Administration; Stereotypic Movement Disorder; Substance-Related Disorders; Synthetic Cathinone | 2013 |
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice.
Topics: Agmatine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurotransmitter Agents; Piperazines; Psychomotor Agitation; Stereotyped Behavior; Time Factors; Ureohydrolases | 2014 |
DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity.
Topics: Allosteric Regulation; Animals; Antidepressive Agents; Antimanic Agents; Calcium; Chlordiazepoxide; Dihydropyridines; HEK293 Cells; Humans; Intracellular Space; Male; Methamphetamine; Mice; Oxazoles; Psychomotor Agitation; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Serotonin; Swimming | 2015 |
Comparison of crystalline methamphetamine ("ice") users and other patients with toxicology-related problems presenting to a hospital emergency department.
Topics: Aggression; Amphetamine-Related Disorders; Central Nervous System Stimulants; Diagnosis, Differential; Emergency Service, Hospital; Humans; Illicit Drugs; Methamphetamine; Psychomotor Agitation | 2008 |
Effect of bee venom acupuncture on methamphetamine-induced hyperactivity, hyperthermia and Fos expression in mice.
Topics: Acupuncture Therapy; Adrenergic alpha-2 Receptor Antagonists; Anesthetics, Local; Animals; Bee Venoms; Brain; Central Nervous System Stimulants; Fever; Humans; Idazoxan; Lidocaine; Male; Methamphetamine; Mice; Neurons, Afferent; Proto-Oncogene Proteins c-fos; Psychomotor Agitation; Substance-Related Disorders | 2011 |
Emergency department visits after use of a drug sold as "bath salts"--Michigan, November 13, 2010-March 31, 2011.
Topics: Adult; Benzodioxoles; Designer Drugs; Emergency Service, Hospital; Female; Hallucinations; Humans; Male; Methamphetamine; Michigan; Middle Aged; Psychomotor Agitation; Pyrrolidines; Substance-Related Disorders; Synthetic Cathinone; Tachycardia; Young Adult | 2011 |
Psychiatric implications of adolescent methamphetamine exposures.
Topics: Adolescent; Akathisia, Drug-Induced; California; Child; Drug Overdose; Female; Fever; Hallucinations; Humans; Male; Medical Records; Methamphetamine; Poison Control Centers; Psychology, Adolescent; Psychomotor Agitation; Retrospective Studies; Seizures; Substance-Related Disorders; Suicidal Ideation; Suicide, Attempted | 2012 |
Methamphetamine and amphetamine concentrations in survivors of body-packer syndrome in Japan.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Crime; Foreign Bodies; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Gastrointestinal Tract; Humans; Illicit Drugs; Intestinal Obstruction; Japan; Limit of Detection; Male; Methamphetamine; Psychomotor Agitation; Radiography; Seizures; Tachycardia | 2013 |
Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Prefrontal Cortex; Psychomotor Agitation; Psychoses, Substance-Induced | 2008 |
Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Dicyclomine; Dopamine; Drug Interactions; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Muscarinic Antagonists; Psychomotor Agitation; Receptor, Muscarinic M1; RNA, Messenger; Time Factors | 2008 |